Office of Research & Development |
|
Project Number: | I21BX005935-01A2 |
Title: | Validation of Dihydroorotate Dehydrogenase as a Therapeutic Target in Mesothelioma |
Principal Investigator: | Mark Klein |
Location: | Minneapolis, MN |
Congressional District Code: | 5 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | May 2024 - April 2026 |
FY 2025 Funding Amount: | $83,000 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |